The relationship of metabolic syndrome and constitutional medicine for the prediction of cardiovascular disease

被引:26
|
作者
Cho, Nam H. [1 ]
Kim, Jong Yeol [2 ]
Kim, Sung Soo [3 ]
Shin, Chol [4 ]
机构
[1] Ajou Univ, Sch Med, Dept Prevent Med, 5 Wonchon Dong, Suwon 443721, Gyeonggi Do, South Korea
[2] Korea Inst Oriental Med, Div Constitut Med & Diag Res Grp, Daejeon, South Korea
[3] Korean Ctr Dis Control & Prevent, Korean Natl Genome Inst, Osong, South Korea
[4] Korea Univ, Ansan Hosp, Coll Med, Dept Pulm Sleep & Crit Care Med, Ansan, South Korea
基金
新加坡国家研究基金会;
关键词
Sasang constitutional medicine; Metabolic syndrome; Cardiovascular disease;
D O I
10.1016/j.dsx.2013.08.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The concept of Sasang Constitutional Medicine (SCM) has been in existence in Traditional Korean Medicine for more than 100 years. SCM consists of 4 different types; So-Eum (SE), So-Yang (SY), Tae-Eum (TE), and Tae-Yang (TY). In Western medicine, it is more like stratifying individuals according to phenotypic expression. It is of great importance that the Sasang constitution type be evaluated accurately and recognized by the medical communities for prevention, early diagnosis and treatment of cardiovascular diseases (CVD). Subjects and methods: From the Ansung-Ansan prospective cohort study, 10,038 participants were recruited from years 2001-2002. Of 10,038 original participants, 3022 subjects underwent Sasang Constitutional Type (SCT) evaluation. The Cox proportional hazard model was used to predict CVD during the ten year follow-up period. Results: Of 3022 participants, SCT classified into 364 (12%) SE, 1053 (34.8%) SY, 1605 (53.1%) TE, and no TY. Three hundred seventy nine (16%) newly developed CVD during the following period, yielding 10-year cumulative incidence of 160/1000 person. The frequency of CVD within three SCT without metabolic syndrome (MetS) shows 13.4% in SE, 13.6% in SY, and 14.3% in TE, respectively (p = NS). The CVD events were significantly different among the types when MetS was present. The demographic and clinical characteristics revealed the TE group was significantly older, more obese, higher blood pressure, glucose values, and lipid profiles levels. The frequency of MetS and type 2 diabetes mellitus (T2DM) was also higher in TE type than either SE and SY types (all p < 0.001). The Cox proportional hazard analysis revealed age, female gender, rural residence, higher ALT level, and lower beta-cell function remain as an independent risk factor, as well as SY with MetS (RR = 1.838 (95% CI 1.23-2.74), p = 0.003). Furthermore, 10 year CVD survival rate was 86.4% in no MetS group, 83.4% in TE, 79.6% in SE, and 76.4% in SY all with MetS (p < 0.001). Conclusions: The findings from this study suggest MetS increases risk for CVD in certain physical conditions like SY type. Therefore, we would like to suggest that SCT is a strong indicator for CVD. (C) 2013 Diabetes India. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:226 / 232
页数:7
相关论文
共 50 条
  • [1] Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease
    Anand, SS
    Yi, QL
    Gerstein, H
    Lonn, E
    Jacobs, R
    Vuksan, V
    Teo, K
    Davis, B
    Montague, P
    Yusuf, S
    CIRCULATION, 2003, 108 (04) : 420 - 425
  • [2] Metabolic syndrome and cardiovascular risk prediction in peripheral arterial disease
    Laurenzano, E.
    Brevetti, G.
    Giugliano, G.
    Lanero, S.
    Sirico, G.
    Brevetti, L.
    Luciano, R.
    Chiariello, M.
    EUROPEAN HEART JOURNAL, 2009, 30 : 987 - 987
  • [3] Metabolic syndrome and cardiovascular risk prediction in peripheral arterial disease
    Brevetti, G.
    Laurenzano, E.
    Giugliano, G.
    Lanero, S.
    Brevetti, L.
    Luciano, R.
    Chiariello, M.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2010, 20 (09) : 676 - 682
  • [4] A relationship of cardiovascular disease between each metabolic component in patients with metabolic syndrome in China
    Guo, Xiao-shan
    Li, Si-jin
    Wu, Zhi-fang
    Liu, Hai-yan
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [5] Metabolic syndrome and cardiovascular disease
    Qiao, Qing
    Gao, Weiguo
    Zhang, Lei
    Nyamdorj, Regzedmaa
    Tuomilehto, Jaakko
    ANNALS OF CLINICAL BIOCHEMISTRY, 2007, 44 : 232 - 263
  • [6] The metabolic syndrome and cardiovascular disease
    Vitarius, JA
    MOUNT SINAI JOURNAL OF MEDICINE, 2005, 72 (04): : 257 - 262
  • [7] THE RELATIONSHIP OF METABOLIC SYNDROME AND CARDIOVASCULAR DISEASE AND MORTALITY IN MAINTENANCE HEMODIALYSIS PATIENTS
    Yu Ling
    Li Han
    Wang Shi-Xiang
    HEART, 2013, 99 : A53 - A53
  • [8] The metabolic syndrome and cardiovascular disease
    Bonora, E
    ANNALS OF MEDICINE, 2006, 38 (01) : 64 - 80
  • [9] CARDIOVASCULAR RISK FACTORS AND THE RELATIONSHIP WITH METABOLIC SYNDROME AND CHRONIC KIDNEY DISEASE
    Caldararu, Carmen D.
    Gliga, Mirela L.
    Tarta, Ionut D.
    Szanto, Annamaria
    Carlan, Otilia
    Dogaru, Grigore A.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 : 133 - 134
  • [10] The metabolic syndrome mediates the relationship between cynical hostility and cardiovascular disease
    Nelson, TL
    Palmer, RF
    Pedersen, NL
    EXPERIMENTAL AGING RESEARCH, 2004, 30 (02) : 163 - 177